CANCER PATENT REVOKED BY CIPLA
Cipla is again in news. This time it is for the revocation of a cancer patent owned by a multinational company. The patent is an Indian Patent IN209251 and it was granted to Pfizer/ Sugen for their cancer drug Sunitinib. The Patent for Sunitinib was granted to Pfizer/ Sugen on 23-08-2007 with an allotment [...]